Plasma prolactin and prostate cancer risk: A prospective study

International Journal of Cancer

Volumn 92, Issue 3, 2001, Pages 463-465

  Stattin, Pär ^a   Rinaldi, Sabina ^a   Stenman, Ulf Hakan ^b   Riboli, Elio ^b   Hallmans, Gran ^c   Bergh, Anders ^c   Kaaks, Rudolf ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Plasma; Prospective study; Prostate cancer risk prolactin; Prostatic neoplasm; Sweden

Indexed keywords

PROLACTIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; TESTOSTERONE;

ARTICLE; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; FOLLOW UP; HEALTH SURVEY; HEIGHT; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; PROSTATE CANCER; SWEDEN; TESTOSTERONE BLOOD LEVEL; WEIGHT;

ADULT; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROLACTIN; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0035342584     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1191     Document Type: Article

References (31)

1. Prolactin and prolactin receptors are expressed and functioning in human prostate
2. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate
3. Coregulatory effects of epidermal growth factor, dihydrotestosterone, and prolactin on benign human prostatic hyperplasia tissue culture proliferation
4. Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r
5. Differential effects of prolactin on rat dorsolateral prostate and R3327 prostatic tumor sublines
6. Evidence for a role of prolactin in prostate and seminal vesicle growth in immature male rats
7. Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture
8. Effect of prolactin on the prostate
9. Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland
10. Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar rats
11. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine
12. Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions
13. Influence of age on serum prolactin levels in women and men
14. Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls
15. High serum prolactin associated with poor prognosis in carcinoma of the prostate
16. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer
17. Measurements of prolactin and androgens in patients with prostatic diseases
18. Prospective study of sex hormone levels and risk of prostate cancer
19. Serological precursors of cancer: Serum hormones and risk of subsequent prostate cancer
20. Leptin is associated with increased risk of myocardial infarction
21. Comparison between diagnoses in the Stockholm Regional Cancer Register and certified underlying causes of death
22. Plasma insulin-like growth factor-I, insulin-like growth factor binding proteins, and prostate cancer risk: A prospective study
23. Psychological stress and neuroendocrine function in humans: The last two decades of research
24. Growth hormone and prolactin variants in normal subjects. Relative proportions in morning and afternoon samples
25. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women
26. Reliability of serum prolactin measurements in women
27. Glycosylated human prolactin: Alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay
28. Structural variants of prolactin: Occurrence and physiological significance
29. Characterization of big, big prolactin in patients with prolactinaemia
30. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
31. Proteolytic degradation and modification of rat prolactin by subcellular fractions of the rat ventral prostate gland